| Antifungal resistance and new strategies to control fungal infections P Vandeputte, S Ferrari, AT Coste International journal of microbiology 2012 (1), 713687, 2012 | 759 | 2012 |
| A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans A Coste, V Turner, F Ischer, J Morschhäuser, A Forche, A Selmecki, ... Genetics 172 (4), 2139-2156, 2006 | 486 | 2006 |
| TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 AT Coste, M Karababa, F Ischer, J Bille, D Sanglard Eukaryotic cell 3 (6), 1639-1652, 2004 | 482 | 2004 |
| Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells F Sierro, B Dubois, A Coste, D Kaiserlian, JP Kraehenbuhl, JC Sirard Proceedings of the National Academy of Sciences 98 (24), 13722-13727, 2001 | 435 | 2001 |
| Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates A Coste, A Selmecki, A Forche, D Diogo, ME Bougnoux, C d'Enfert, ... Eukaryotic cell 6 (10), 1889-1904, 2007 | 377 | 2007 |
| Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation D Sanglard, A Coste, S Ferrari FEMS yeast research 9 (7), 1029-1050, 2009 | 376 | 2009 |
| Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture? S Berger, Y El Chazli, AF Babu, AT Coste Frontiers in microbiology 8, 1024, 2017 | 257 | 2017 |
| CRZ1, a target of the calcineurin pathway in Candida albicans M Karababa, E Valentino, G Pardini, AT Coste, J Bille, D Sanglard Molecular microbiology 59 (5), 1429-1451, 2006 | 249 | 2006 |
| Changes in SARS-CoV-2 spike versus nucleoprotein antibody responses impact the estimates of infections in population-based seroprevalence studies C Fenwick, A Croxatto, AT Coste, F Pojer, C André, C Pellaton, A Farina, ... Journal of virology 95 (3), 10.1128/jvi. 01828-20, 2021 | 234 | 2021 |
| Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug … M Karababa, AT Coste, B Rognon, J Bille, D Sanglard Antimicrobial agents and chemotherapy 48 (8), 3064-3079, 2004 | 214 | 2004 |
| Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris F Chaabane, A Graf, L Jequier, AT Coste Frontiers in microbiology 10, 2788, 2019 | 197 | 2019 |
| Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results G Caruana, A Croxatto, AT Coste, O Opota, F Lamoth, K Jaton, G Greub Clinical Microbiology and Infection 26 (9), 1178-1182, 2020 | 186 | 2020 |
| Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals J Eddouzi, JE Parker, LA Vale-Silva, A Coste, F Ischer, S Kelly, M Manai, ... Antimicrobial agents and chemotherapy 57 (7), 3182-3193, 2013 | 156 | 2013 |
| The importance of antimicrobial resistance in medical mycology NAR Gow, C Johnson, J Berman, AT Coste, CA Cuomo, DS Perlin, ... Nature communications 13 (1), 5352, 2022 | 151 | 2022 |
| Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection DM MacCallum, A Coste, F Ischer, MD Jacobsen, FC Odds, D Sanglard Antimicrobial agents and chemotherapy 54 (4), 1476-1483, 2010 | 140 | 2010 |
| The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans G Pardini, PWJ De Groot, AT Coste, M Karababa, FM Klis, CG de Koster, ... Journal of Biological Chemistry 281 (52), 40399-40411, 2006 | 133 | 2006 |
| Azole Resistance by Loss of Function of the Sterol Δ5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence LA Vale-Silva, AT Coste, F Ischer, JE Parker, SL Kelly, E Pinto, ... Antimicrobial agents and chemotherapy 56 (4), 1960-1968, 2012 | 114 | 2012 |
| Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System AT Coste, J Crittin, C Bauser, B Rohde, D Sanglard Eukaryotic Cell 8 (8), 1250-1267, 2009 | 108 | 2009 |
| Distinct Roles of Candida albicans Drug Resistance Transcription Factors TAC1, MRR1, and UPC2 in Virulence A Lohberger, AT Coste, D Sanglard Eukaryotic Cell 13 (1), 127-142, 2014 | 103 | 2014 |
| Comparison of SARS-CoV-2 serological tests with different antigen targets AT Coste, K Jaton, M Papadimitriou-Olivgeris, G Greub, A Croxatto Journal of clinical virology 134, 104690, 2021 | 93 | 2021 |
SanglardUniversity of Lausanne and University Hospital CenterEmail verificata su chuv.ch